Clinical Trials Logo

Peptic Ulcer clinical trials

View clinical trials related to Peptic Ulcer.

Filter by:

NCT ID: NCT00161096 Active, not recruiting - GERD Clinical Trials

On-Demand Use of Pantoprazole: Determinants for Chronic Use of Acid Suppressive Medication

Start date: March 2004
Phase: Phase 3
Study type: Interventional

The purpose of this study is to investigate several aspects of chronic use of acid suppressing medication: dependence on maintenance therapy, the possibilities for on-demand use, and predictors (patient characteristics) for daily need, for on-demand use and for termination of chronic use.

NCT ID: NCT00153712 Completed - Peptic Ulcer Clinical Trials

Natural History of Non-steroidal Anti-inflammatory Drug and Non-Helicobacter Pylori in Bleeding Peptic Ulcers

Start date: August 2002
Phase: N/A
Study type: Observational

The aim of this study is to study the natural history of the ulcer healing while on proton pump inhibitors (PPI) and the ulcer recurrence without acid suppression therapy of Non-steroidal Anti-inflammatory Drugs (NSAID), non-Helicobacter pylori (HP) bleeding ulcer patients.

NCT ID: NCT00152399 Completed - Peptic Ulcer Clinical Trials

Study to Assess the Efficacy and Safety of Somatostatin in the Treatment of Acute Severe Upper Gastrointestinal Bleeding

Start date: September 2000
Phase: Phase 2
Study type: Interventional

To assess the efficacy and safety of the early administration of somatostatin in infusion during 72 hours plus 2 boluses, compared to placebo in the control of acute severe UGIB with suspicion of PUB.

NCT ID: NCT00137033 Completed - Peptic Ulcers Clinical Trials

Celebrex Low Dose ASA Study Examining the Incidence of Gastroduodenal Ulcers in a Healthy Population

Start date: September 2004
Phase: Phase 4
Study type: Interventional

The aim of the current study is to replicate the COXA-0508-258 study in a multicenter, US setting, using a lower dose of ASA. It is expected that this study will not only confirm the results of the 258 study but show that the incidence of UGI ulcers on celecoxib is significantly less than on traditional NSAIDs and the incidence of UGI ulcers on celecoxib increases with the addition of ASA, but still is lower than traditional NSAIDs plus/minus ASA. This 7-day study is designed to compare the incidence of gastroduodenal ulcers associated with celecoxib 200 mg QD and low dose aspirin 81 mg QD and with naproxen 500 mg BID plus low dose aspirin 81 mg QD in healthy adults(50-75 years of age).

NCT ID: NCT00040495 Completed - Clinical trials for Peptic Ulcer Hemorrhage

Study Evaluating Pantoprazole in Peptic Ulcer Hemorrhage

Start date: April 2001
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the efficacy and safety of intravenous pantoprazole in the prevention of rebleeding in patients with bleeding peptic ulcer disease after successful endoscopic hemostatic therapy.

NCT ID: NCT00037570 Completed - Clinical trials for Peptic Ulcer Hemorrhage

Study Evaluating Pantoprazole in Peptic Ulcer Hemorrhage

Start date: November 2000
Phase: Phase 2
Study type: Interventional

This is a multicenter, randomized, double-blind, parallel-group, dose-ranging, comparator-controlled study of the effect of pantoprazole on intragastric pH after successful endoscopic hemostasis in hospitalized patients. Patients will receive either intravenous pantoprazole (one of two regimens) or ranitidine (the comparator) within 2 hours of successful hemostasis and administration will continue for 72 hours after hemostasis.